Advertisement

Topics

Erythropoietin Drug Market is Expected to Grow at a CAGR of 9.5 % from 2016 to 2023

04:41 EDT 21 Jun 2017 | Topix

Global erythropoietin drug market research report, by product type by application and by end user - Forecast Till 2023 Major key Players include Hoffmann-La Roche,Johnson & Johnson,Amgen,Kyowa Hakko Kirin,Intas Pharmaceuticals,Teva Pharmaceutical Industries Ltd,Biocon,Emcure Pharmaceuticals" PUNE, MAHARASHTRA, INDIA, June 21, 2017 / EINPresswire.com / -- Market Highlights Erythropoietin drug are used to stimulate the growth of the RBC production. This drugs are used during treatment of cancer, renal diseases, anemia and many more.

Original Article: Erythropoietin Drug Market is Expected to Grow at a CAGR of 9.5 % from 2016 to 2023

NEXT ARTICLE

More From BioPortfolio on "Erythropoietin Drug Market is Expected to Grow at a CAGR of 9.5 % from 2016 to 2023"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...